Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Purposive sample: patients are not randomly selected, that is, he or she must meet certain inclusion criteria in order to qualify as a potential study participant.
Age
6–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children age 6 to 16 (inclusive) with anxiety, depression, or obsessive-compulsive disorder, receiving treatment in outpatient setting, and who are prescribed a new prescription for sertraline to treat one of the above study-qualifying disorders or beginning psychotherapy for same.
You may not be if
Psychotic at study entry
Diagnosis of bipolar disorder
Diagnosis of schizoaffective or schizophrenia
Anorexia
Bulimia or eating disorder not otherwise specified (NOS)
Autism
Pervasive developmental disorder
High risk of suicide within 2 weeks of initiating study treatment
Significant mental retardation
Taking an antidepressant medication other than sertraline, first or second generation antipsychotic, lithium, psychostimulant
